Dr. Margaret Huflejt, TGF grant recipient, discusses her research at New York University and its implications on the future of exfoliation syndrome patients.
"Hello, I'm Margaret Huflejt and I have a PhD in Biochemistry from the University of California, Berkeley. Together with Dr. Harvey Pass, we have established the Glycomics Laboratory in New York University's School of Medicine. We study the immune system and its responses to the earliest signs of various human diseases. We are very grateful to The Glaucoma Foundation which chose to support our research in exfoliation syndrome. The focus of this research is to identify a set of antibodies which show the earliest signs of exfoliation syndrome. This information will allow us to develop validated clinical tests for the early detection of the individual patient's risk of developing exfoliation syndrome. By early detection, we will have tried for preventive intervention which will stop progress of the disease. For us, the ultimate goal is to prevent unnecessary blindness caused by exfoliation syndrome."
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?